Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib with or without oral minoxidil for alopecia areata
RBR-63pbcy3Phase 2Recruiting
- Sponsor
- Ebserh
- Start
- Oct 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alopecia areata, alopecia areata totalis (AT), alopecia universalis (AU) and 1 more comparing Baricitinib + oral minoxidil with Baricitinib + placebo (2 arms). Started Oct 2025; status: recruiting.
02
Drugs
baricitinibminoxidil
03
Conditions
alopecia areataalopecia areata totalis (AT)alopecia universalis (AU)Ophiasis alopecia
Beyond the preview
Go deeper on RBR-63pbcy3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-63pbcy3.